Topadur Pharma is a biopharmaceutical company that develops healthcare drugs for the treatment of aging diseases and medical ailments.
Topadur Pharma has raised $3.4M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in June 2024.
Topadur Pharma's investors include Innosuisse, Oshen, Korea Institute for Advancement of Technology.
Topadur Pharma is headquartered in Schlieren, Switzerland.
Topadur Pharma is a biopharmaceutical company that develops healthcare drugs for the treatment of aging diseases and medical ailments.
Topadur Pharma is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Topadur Pharma — Funding & Investors." VCBacked, June 6, 2024, https://www.vcbacked.co/company/topadur-pharma. Accessed November 12, 2026.
VCBacked. (2024). Topadur Pharma — Funding & Investors. Retrieved November 12, 2026, from https://www.vcbacked.co/company/topadur-pharma
{{cite web |title=Topadur Pharma — Funding & Investors |url=https://www.vcbacked.co/company/topadur-pharma |website=VCBacked |access-date=November 12, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Topadur Pharma? Request a listing update